BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39739)

  • 21. Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine.
    Moore DF
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):172-80. PubMed ID: 809232
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 23. Acutely ill schizophrenic patients treated with loxapine. A clinical study in a community mental health center.
    Rasul M
    Clin Ther; 1980; 3(4):242-9. PubMed ID: 7273062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loxapine succinate: a controlled double-blind study in schizophrenia.
    Charalampous KD; Freemesser GF; Malev J; Ford K
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):829-37. PubMed ID: 4217251
    [No Abstract]   [Full Text] [Related]  

  • 25. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 26. Loxapine concentrate in acute schizophrenia.
    O'Connell RA; Jeewa M; Allen K
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):101-7. PubMed ID: 401704
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of two dose levels of loxapine succinate in chronic schizophrenia.
    Clark ML; Paredes A; Costiloe JP; Fulkerson FG; Wood F
    Dis Nerv Syst; 1977 Jan; 38(1):7-10. PubMed ID: 318984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The assessment of neuroleptogenic extrapyramidal syndroms in psychopharmacological research (author's transl)].
    Mattke DJ; Mombour W; Glötzner FL
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):36-44. PubMed ID: 788001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluations of loxapine succinate in the ambulatory treatment of acute schizophrenic episodes.
    Zisook S; Click MA
    Int Pharmacopsychiatry; 1980; 15(6):365-78. PubMed ID: 7028656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loxapine: a six-month evaluation in severely ill schizophrenic patients.
    Gallant DM; Bishop G; Steel CA; Bishop MP
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):205-9. PubMed ID: 4633281
    [No Abstract]   [Full Text] [Related]  

  • 31. Loxapine succinate: a comparative study with chlorpromazine.
    Dube KC; Kumar N
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):653-60. PubMed ID: 819223
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of loxapine in the treatment of paranoid schizophrenia.
    Bishop MP; Simpson GM; Dunnett CW; Kiltie H
    Psychopharmacology (Berl); 1977 Jan; 51(2):107-15. PubMed ID: 14350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients.
    Simpson GM; Cuculic Z
    J Clin Pharmacol; 1976 Jan; 16(1):60-5. PubMed ID: 1107360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients.
    Kiloh LG; Williams SE; Grant DA; Whetton PS
    J Int Med Res; 1976; 4(6):441-8. PubMed ID: 800384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of loxapine succinate as an anxiolytic in comparison with chlordiazepoxide.
    Mahal AS; Malik SC; Srinivasamurthy U
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):84-93. PubMed ID: 821710
    [No Abstract]   [Full Text] [Related]  

  • 36. Loxapine succinate as initial treatment of hostile and aggressive schizophrenic criminal offenders.
    Feldman HS
    J Clin Pharmacol; 1982; 22(8-9):366-70. PubMed ID: 7130427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loxapine in newly admitted chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F; Barrett A
    J Clin Pharmacol; 1975 Apr; 15(4 Pt 1):286-94. PubMed ID: 1092725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome.
    Irwin GE; Simon JE
    J Emerg Med; 1984; 1(3):207-11. PubMed ID: 6491238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of parenteral loxapine succinate in very disturbed psychotic patients.
    James B; McIntyre M; Hannah J
    N Z Med J; 1982 Feb; 95(702):123-4. PubMed ID: 6952119
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolactin stimulating effects of amoxapine and loxapine in psychiatric patients.
    Robertson AG; Berry R; Meltzer HY
    Psychopharmacology (Berl); 1982; 78(3):287-92. PubMed ID: 6818584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.